“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era

Clayton, 2014, Policy: NIH to balance sex in cell and animal studies, Nature, 509, 282, 10.1038/509282a

Vlassoff, 2007, Gender differences in determinants and consequences of health and illness, J. Health Popul. Nutr., 25, 47

Kimmel, M. (2016). The Gendered Society, Oxford University Press. [6th ed.].

Lips, 2004, The Gender Gap in Possible Selves: Divergence of Academic Self-Views Among High School and University Students, Sex Roles, 50, 357, 10.1023/B:SERS.0000018891.88889.c9

Prakash, 2018, Sex Bias in Interventional Clinical Trials, J. Womens Health, 27, 1342, 10.1089/jwh.2017.6873

Kim, 2010, Sex bias in trials and treatment must end, Nature, 465, 688, 10.1038/465688a

Harris, 2000, Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute, N. Engl. J. Med., 343, 475, 10.1056/NEJM200008173430706

Kim, 2008, Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion, J. Am. Coll. Cardiol., 52, 672, 10.1016/j.jacc.2008.05.025

Mehta, 2016, Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association, Circulation, 133, 916, 10.1161/CIR.0000000000000351

Mostertz, 2010, Age- and sex-specific genomic profiles in non-small cell lung cancer, JAMA, 303, 535, 10.1001/jama.2010.80

Franconi, 2015, Need for gender-specific pre-analytical testing: The dark side of the moon in laboratory testing, Int. J. Cardiol., 179, 514, 10.1016/j.ijcard.2014.11.019

McCullough, 2014, NIH initiative to balance sex of animals in preclinical studies: Generative questions to guide policy, implementation, and metrics, Biol. Sex Differ., 5, 15, 10.1186/s13293-014-0015-5

Zucker, 2010, Males still dominate animal studies, Nature, 465, 690, 10.1038/465690a

Veliskova, 2007, Estrogens and epilepsy: Why are we so excited?, Neuroscientist, 13, 77, 10.1177/1073858406295827

Gold, 2009, Estrogen treatment in multiple sclerosis, J. Neurol. Sci., 286, 99, 10.1016/j.jns.2009.05.028

Rosvall, K.A., Bentz, A.B., and George, E.M. (2019). How research on female vertebrates contributes to an expanded challenge hypothesis. Horm. Behav., 104565.

Legato, 2016, Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes, JAMA, 316, 1865, 10.1001/jama.2016.13995

(2010). Putting gender on the agenda. Nature, 465, 665.

Blaustein, 2012, Animals have a sex, and so should titles and methods sections of articles in Endocrinology, Endocrinology, 153, 2539, 10.1210/en.2012-1365

Yang, 2006, Tissue-specific expression and regulation of sexually dimorphic genes in mice, Genome Res., 16, 995, 10.1101/gr.5217506

Dalibert, 2017, Implementation Strategies for Gender-Sensitive Public Health Practice: A European Workshop, J. Womens Health, 26, 1255, 10.1089/jwh.2017.6592

Kaminsky, 2006, Complex disease, gender and epigenetics, Ann. Med., 38, 530, 10.1080/07853890600989211

Sioud, 2007, Treatment options and individualized medicine, Methods Mol. Biol., 361, 327

Franconi, 2017, Sex and gender landscape in pharmacology, Pharmacol. Res., 123, 93, 10.1016/j.phrs.2017.07.001

Rodriquez, 2015, Is it time to integrate sex and gender into drug design and development?, Future Med. Chem., 7, 557, 10.4155/fmc.15.17

Franconi, 2014, Sex and gender influences on pharmacological response: An overview, Expert Rev. Clin. Pharmacol., 7, 469, 10.1586/17512433.2014.922866

Basili, 2015, Impact of sex and gender on the efficacy of antiplatelet therapy: The female perspective, J. Atheroscler. Thromb., 22, 109, 10.5551/jat.24935

Passacquale, 2017, Gender differences in cardiovascular prophylaxis: Focus on antiplatelet treatment, Pharmacol. Res., 119, 36, 10.1016/j.phrs.2017.01.025

Pucci, 2017, Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature, Pharmacol. Res., 120, 34, 10.1016/j.phrs.2017.03.008

Campesi, 2017, Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes, Pharmacol. Res., 119, 195, 10.1016/j.phrs.2017.01.023

Franconi, F., Campesi, I., Colombo, D., and Antonini, P. (2019). Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies. Cells, 8.

Chen, 2013, Promise of personalized omics to precision medicine, Wiley Interdiscip. Rev. Syst. Biol. Med., 5, 73, 10.1002/wsbm.1198

Baetta, 2018, Reprint of: Proteomics in cardiovascular diseases: Unveiling sex and gender differences in the era of precision medicine, J. Proteom., 178, 57, 10.1016/j.jprot.2018.03.017

Legato, 2016, Gender-specific medicine in the genomic era, Clin. Sci., 130, 1, 10.1042/CS20150551

Miller, 2014, Why are sex and gender important to basic physiology and translational and individualized medicine?, Am. J. Physiol. Heart Circ. Physiol., 306, H781, 10.1152/ajpheart.00994.2013

Legato, M.J. (2019, December 13). The “Biological Sex”. Available online: http://www.genderbasic.nl/.

Legato, 2011, The “ biological sex or gender?” debate: “Everything flows, nothing stands still. Nothing endures but change”, Gend. Med., 8, 161, 10.1016/j.genm.2011.02.004

Klinge, 2008, Gender perspectives in European research, Pharmacol. Res., 58, 183, 10.1016/j.phrs.2008.07.011

(2019, December 13). Available online: https://cordis.europa.eu/project/id/18833.

(2019, December 13). Available online: https://eupha.org/gencad.

(2019, December 13). Available online: http://www.eugenmed.eu/index.php/eugennet.

Cardiovascular Clinical Study Group, Regitz-Zagrosek, V., Oertelt-Prigione, S., Prescott, E., Franconi, F., Gerdts, E., Foryst-Ludwig, A., Maas, A.H., Kautzky-Willer, A., and Knappe-Wegner, D. (2016). Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur. Heart J., 37, 24–34.

Dworatzek, 2017, Sex in basic research: Concepts in the cardiovascular field, Cardiovasc. Res., 113, 711, 10.1093/cvr/cvx066

(2019, December 13). Available online: https://eige.europa.eu/about.

(2019, October 24). Available online: http://www.worldheartfailure.org/WHFS.

(2019, October 24). Available online: http://www.medicographia.com/2012/02/the-heart-failure-epidemic.

Davis, 2017, “Mind the gap” acute coronary syndrome in women: A contemporary review of current clinical evidence, Int. J. Cardiol., 227, 840, 10.1016/j.ijcard.2016.10.020

2018, Gender and cardiovascular disease in the workplace—It’s not just about pay gaps, Int. J. Cardiol., 262, 108, 10.1016/j.ijcard.2018.03.106

Myocardial Infarction Genetics Consortium, Kathiresan, S., Voight, B.F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P.M., Anand, S., Engert, J.C., and Samani, N.J. (2009). Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet., 41, 334–341.

Nakatochi, 2017, Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease, Clin. Epigenet., 9, 54, 10.1186/s13148-017-0353-3

Webb, 2017, Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease, J. Am. Coll. Cardiol., 69, 823, 10.1016/j.jacc.2016.11.056

Chaudhary, R., Sukhi, A., Chaudhary, R., Jindal, M., Vyas, A., Rout, A., Bliden, K., Tantry, U., and Gurbel, P. (2019). Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease. J. Thromb. Thrombolysis.

Patel, R., Tragante, V., Schmidt, A.F., McCubrey, R.O., Holmes, M.V., Howe, L.J., Direk, K., Akerblom, A., Leander, K., and Virani, S.S. (2019). Subsequent Event Risk in Individuals with Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium. Circ. Genom. Precis. Med.

Gemmati, 1999, C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients, Haematologica, 84, 824

Gemmati, 2001, A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases, Am. J. Hematol., 67, 183, 10.1002/ajh.1104

Campo, 2006, Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events, Arterioscler. Thromb. Vasc. Biol., 26, 2800, 10.1161/01.ATV.0000247249.82030.94

Gemmati, 2007, Factor XIIIA-V34L and factor XIIIB-H95R gene variants: Effects on survival in myocardial infarction patients, Mol. Med., 13, 112, 10.2119/2006-00049.Gemmati

Gemmati, 2015, Factor XIII-A dynamics in acute myocardial infarction: A novel prognostic biomarker?, Thromb. Haemost., 114, 123, 10.1160/TH14-11-0952

Gemmati, 2016, Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics, Curr. Pharm. Des., 22, 1449, 10.2174/1381612822666151210122954

Ansani, L., Marchesini, J., Pestelli, G., Luisi, G.A., Scillitani, G., Longo, G., Milani, D., Serino, M.L., Tisato, V., and Gemmati, D. (2018). F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty. Int. J. Mol. Sci., 19.

De Luca, L., Marini, M., Gonzini, L., Boccanelli, A., Casella, G., Chiarella, F., De Servi, S., Di Chiara, A., Di Pasquale, G., and Olivari, Z. (2016). Contemporary Trends and Age-Specific Sex Differences in Management and Outcome for Patients With ST-Segment Elevation Myocardial Infarction. J. Am. Heart Assoc., 5.

Dreyer, 2015, Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction, Circulation, 132, 158, 10.1161/CIRCULATIONAHA.114.014776

Dreyer, 2017, Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study, Circulation, 135, 521, 10.1161/CIRCULATIONAHA.116.024993

Mozaffarian, 2016, Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association, Circulation, 133, e38

Wells, 2016, Cardiovascular Risk Factors: Does Sex Matter?, Curr. Vasc. Pharmacol., 14, 452, 10.2174/1570161114666160722113116

Dunlay, 2012, Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure, Curr. Heart Fail. Rep., 9, 267, 10.1007/s11897-012-0107-7

Seeland, U., and Regitz-Zagrosek, V. (2012). Sex and gender differences in cardiovascular drug therapy. Handb. Exp. Pharmacol., 211–236.

Ranasinghe, I., Wang, Y., Dharmarajan, K., Hsieh, A.F., Bernheim, S.M., and Krumholz, H.M. (2014). Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: A retrospective observational cohort study. PLoS Med., 11.

Bauters, C., Dubois, E., Porouchani, S., Saloux, E., Fertin, M., de Groote, P., Lamblin, N., and Pinet, F. (2017). Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice. PLoS ONE, 12.

Subramanya, 2018, Sex hormone levels and change in left ventricular structure among men and post-menopausal women: The Multi-Ethnic Study of Atherosclerosis (MESA), Maturitas, 108, 37, 10.1016/j.maturitas.2017.11.006

Hakimzadeh, 2015, Modulators of Macrophage Polarization Influence Healing of the Infarcted Myocardium, Int. J. Mol. Sci., 16, 29583, 10.3390/ijms161226187

Chistiakov, D.A., Orekhov, A.N., and Bobryshev, Y.V. (2016). Cardiac Extracellular Vesicles in Normal and Infarcted Heart. Int. J. Mol. Sci., 17.

Musial-Wysocka, A., Kot, M., Sulkowski, M., and Majka, M. (2019). Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia. Int. J. Mol. Sci., 20.

Sun, T., Dong, Y.H., Du, W., Shi, C.Y., Wang, K., Tariq, M.A., Wang, J.X., and Li, P.F. (2017). The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application. Int. J. Mol. Sci., 18.

Singh, 2010, Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer, Int. J. Low Extrem. Wounds, 9, 166, 10.1177/1534734610384653

Zamboni, 2007, Clinical implications of gene polymorphisms in venous leg ulcer: A model in tissue injury and reparative process, Thromb. Haemost., 98, 131, 10.1160/TH06-11-0625

Zamboni, 2004, Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells, Vasc. Endovasc. Surg., 38, 431, 10.1177/153857440403800506

Tognazzo, 2006, Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers, J. Vasc. Surg., 44, 815, 10.1016/j.jvs.2006.06.006

Gemmati, 2006, Influence of gene polymorphisms in ulcer healing process after superficial venous surgery, J. Vasc. Surg., 44, 554, 10.1016/j.jvs.2006.05.011

Gemmati, 2004, Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension, Wound Repair Regen., 12, 512, 10.1111/j.1067-1927.2004.012503.x

Gemmati, 2018, Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: Identification of gender prognostic indicators, Sci. Rep., 8, 16916, 10.1038/s41598-018-35185-x

Greiten, 2014, Should there be sex-specific criteria for the diagnosis and treatment of heart failure?, J. Cardiovasc. Transl. Res., 7, 139, 10.1007/s12265-013-9514-8

Falzone, 2018, Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium, Front. Pharmacol., 9, 1300, 10.3389/fphar.2018.01300

(2019, October 24). Available online: www.istat.it/it/archivio/230897.

Clocchiatti, 2016, Sexual dimorphism in cancer, Nat. Rev. Cancer, 16, 330, 10.1038/nrc.2016.30

Straface, E., Gambardella, L., Brandani, M., and Malorni, W. (2012). Sex differences at cellular level: “Cells have a sex”. Handb. Exp. Pharmacol., 49–65.

Carrel, 2005, X-inactivation profile reveals extensive variability in X-linked gene expression in females, Nature, 434, 400, 10.1038/nature03479

Pinheiro, 2011, X-chromosome-located microRNAs in immunity: Might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signalling, thereby contributing to the enhanced immune response of females, Bioessays, 33, 791, 10.1002/bies.201100047

Capone, 2018, Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy, Front. Immunol., 9, 552, 10.3389/fimmu.2018.00552

Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90

Gabriele, 2016, The gender perspective in cancer research and therapy: Novel insights and on-going hypotheses, Ann. Ist. Super. Sanita, 52, 213

Kim, 2015, Sex- and gender-specific disparities in colorectal cancer risk, World J. Gastroenterol., 21, 5167, 10.3748/wjg.v21.i17.5167

Salem, 2017, Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers, Oncotarget, 8, 86356, 10.18632/oncotarget.21169

Marks, 2016, Female with bladder cancer: What and why is there a difference?, Transl. Androl. Urol., 5, 668, 10.21037/tau.2016.03.22

Gupta, S., Artomov, M., Goggins, W., Daly, M., and Tsao, H. (2015). Gender Disparity and Mutation Burden in Metastatic Melanoma. J. Natl. Cancer Inst., 107.

Roh, 2017, Cutaneous melanoma in women, Int. J. Womens Dermatol., 3, S11, 10.1016/j.ijwd.2017.02.003

Faramarzi, 2017, Melanoma: A prototype of cancer-testis antigen-expressing malignancies, Immunotherapy, 9, 1103, 10.2217/imt-2017-0091

Botticelli, 2017, The sexist behaviour of immune checkpoint inhibitors in cancer therapy?, Oncotarget, 8, 99336, 10.18632/oncotarget.22242

Conforti, 2018, Cancer immunotherapy efficacy and patients’ sex: A systematic review and meta-analysis, Lancet Oncol., 19, 737, 10.1016/S1470-2045(18)30261-4

Grassadonia, A., Sperduti, I., Vici, P., Iezzi, L., Brocco, D., Gamucci, T., Pizzuti, L., Maugeri-Sacca, M., Marchetti, P., and Cognetti, G. (2018). Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials. J. Clin. Med., 7.

Care, 2018, Sex disparity in cancer: Roles of microRNAs and related functional players, Cell Death Differ., 25, 477, 10.1038/s41418-017-0051-x

Weng, 2018, Clinical and molecular characteristics associated with the efficacy of PD-1/PD-L1 inhibitors for solid tumors: A meta-analysis, OncoTargets Ther., 11, 7529, 10.2147/OTT.S167865

Hanamsagar, 2016, Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development, J. Steroid Biochem. Mol. Biol., 160, 127, 10.1016/j.jsbmb.2015.09.039

Ullah, 2019, Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders, Neurosci. Biobehav. Rev., 102, 95, 10.1016/j.neubiorev.2019.04.003

Harbo, 2013, Sex and gender issues in multiple sclerosis, Ther. Adv. Neurol. Disord., 6, 237, 10.1177/1756285613488434

Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7

Karussis, 2014, The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review, J. Autoimmun., 48-49, 134, 10.1016/j.jaut.2014.01.022

Airas, 2012, Pregnancy and multiple sclerosis, Obstet. Med., 5, 94, 10.1258/om.2012.110014

Fainardi, 2009, Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis, Mult. Scler., 15, 547, 10.1177/1352458509102372

Trentini, 2015, TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis, Mult. Scler., 21, 1121, 10.1177/1352458514560925

Trentini, 2016, Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients, Dis. Markers, 2016, 3672353, 10.1155/2016/3672353

Kallaur, 2013, Cytokine profile in relapsingremitting multiple sclerosis patients and the association between progression and activity of the disease, Mol. Med. Rep., 7, 1010, 10.3892/mmr.2013.1256

Khaibullin, 2017, Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients, Front. Immunol., 8, 531, 10.3389/fimmu.2017.00531

Trentini, 2014, N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis, J. Neurol., 261, 2338, 10.1007/s00415-014-7507-4

Khalil, 2013, CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome, Mult. Scler., 19, 436, 10.1177/1352458512458010

Bridel, C., van Wieringen, W.N., Zetterberg, H., Tijms, B.M., Teunissen, C.E., Alvarez-Cermeno, J.C., Andreasson, U., Axelsson, M., Backstrom, D.C., and Bartos, A. (2019). Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol.

Hamedani, 2016, Up regulation of MMP9 gene expression in female patients with multiple sclerosis, Hum. Antibodies, 24, 59, 10.3233/HAB-160292

Gold, 2009, Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha), Lab. Invest., 89, 1076, 10.1038/labinvest.2009.79

Castellazzi, 2018, Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients, Front. Neurol., 9, 1080, 10.3389/fneur.2018.01080

Powell, 2015, Review of the Multiscale Effects of Female Sex Hormones on Matrix Metalloproteinase-Mediated Collagen Degradation, Crit. Rev. Biomed. Eng., 43, 401, 10.1615/CritRevBiomedEng.2016016590

Ramien, 2016, Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis, Neurosci. Biobehav. Rev., 67, 137, 10.1016/j.neubiorev.2015.12.015

Kovats, 2015, Estrogen receptors regulate innate immune cells and signalling pathways, Cell Immunol., 294, 63, 10.1016/j.cellimm.2015.01.018

Lai, 2012, Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: Lessons from conditional AR knockout mice, Am. J. Pathol., 181, 1504, 10.1016/j.ajpath.2012.07.008

Soldan, 2003, Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol, J. Immunol., 171, 6267, 10.4049/jimmunol.171.11.6267

Pelfrey, 2002, Sex differences in cytokine responses to myelin peptides in multiple sclerosis, J. Neuroimmunol., 130, 211, 10.1016/S0165-5728(02)00224-2

Eikelenboom, 2005, Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis, Mult. Scler., 11, 520, 10.1191/1352458505ms1195oa

Nguyen, 2003, Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients, J. Neurol. Sci., 209, 93, 10.1016/S0022-510X(03)00004-2

Eikelenboom, 2009, Gender differences in multiple sclerosis: Cytokines and vitamin D, J. Neurol. Sci., 286, 40, 10.1016/j.jns.2009.06.025

Lin, 2018, Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease, Sci. Rep., 8, 17368, 10.1038/s41598-018-35766-w

Pawlitzki, 2018, CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration, Front. Neurol., 9, 1037, 10.3389/fneur.2018.01037

Kuhle, 2019, Blood neurofilament light chain as a biomarker of MS disease activity and treatment response, Neurology, 92, e1007, 10.1212/WNL.0000000000007032

Bergman, 2016, Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS, Neurol. Neuroimmunol. Neuroinflamm., 3, e271, 10.1212/NXI.0000000000000271

Gemmati, D., Zeri, G., Orioli, E., De Gaetano, F.E., Salvi, F., Bartolomei, I., D’Alfonso, S., Dall’osso, C., Leone, M.A., and Singh, A.V. (2012). Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis. BMC Med. Genet., 13.

Sheykhansari, 2018, Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: A review, Cell Death Dis., 9, 348, 10.1038/s41419-018-0379-2

Ziliotto, 2019, C6orf10 Low-Frequency and Rare Variants in Italian Multiple Sclerosis Patients, Front. Genet., 10, 573, 10.3389/fgene.2019.00573

Ferlini, A., Bovolenta, M., Neri, M., Gualandi, F., Balboni, A., Yuryev, A., Salvi, F., Gemmati, D., Liboni, A., and Zamboni, P. (2010). Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis. BMC Med. Genet., 11.

Paraboschi, 2011, Genetic association and altered gene expression of mir-155 in multiple sclerosis patients, Int. J. Mol. Sci., 12, 8695, 10.3390/ijms12128695

Paraboschi, 2014, Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis, Hum. Mol. Genet., 23, 6746, 10.1093/hmg/ddu392

Paraboschi, 2015, Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes, Int. J. Mol. Sci., 16, 23463, 10.3390/ijms161023463

(2019, December 08). Available online: https://www.who.int/mental_health/neurology/dementia/en/.

Prince, 2013, The global prevalence of dementia: A systematic review and metaanalysis, Alzheimers Dement., 9, 63, 10.1016/j.jalz.2012.11.007

Sleegers, 2016, The genetic landscape of Alzheimer disease: Clinical implications and perspectives, Genet. Med., 18, 421, 10.1038/gim.2015.117

Wang, 2019, Lifespan Intellectual Factors, Genetic Susceptibility, and Cognitive Phenotypes in Aging: Implications for Interventions, Front. Aging Neurosci., 11, 129, 10.3389/fnagi.2019.00129

Podcasy, 2016, Considering sex and gender in Alzheimer disease and other dementias, Dialogues Clin. Neurosci., 18, 437, 10.31887/DCNS.2016.18.4/cepperson

Mielke, 2018, Sex and Gender Differences in Alzheimer’s Disease Dementia, Psychiatr. Times, 35, 14

Laws, 2018, Sex differences in Alzheimer’s disease, Curr. Opin. Psychiatry, 31, 133, 10.1097/YCO.0000000000000401

Wolters, 2019, Epidemiology of Vascular Dementia, Arterioscler. Thromb. Vasc. Biol., 39, 1542, 10.1161/ATVBAHA.119.311908

Robison, 2019, Contributions of sex to cerebrovascular function and pathology, Brain Res., 1710, 43, 10.1016/j.brainres.2018.12.030

Eid, 2019, Gene-environment interactions in Alzheimer’s disease: A potential path to precision medicine, Pharmacol. Ther., 199, 173, 10.1016/j.pharmthera.2019.03.005

Belloy, 2019, A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward, Neuron, 101, 820, 10.1016/j.neuron.2019.01.056

Rasmussen, 2018, Absolute 10-year risk of dementia by age, sex and APOE genotype: A population-based cohort study, CMAJ, 190, E1033, 10.1503/cmaj.180066

Hansen, D., Ling, H., Lashley, T., Holton, J.L., and Warner, T.T. (2019). Review: Clinical, neuropathological and genetic features of Lewy body dementias. Neuropathol. Appl. Neurobiol.

Pang, 2018, Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson’s Disease Dementia, Parkinsons Dis., 2018, 9497147

Reinvang, 2013, APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease, Neurosci. Biobehav. Rev., 37, 1322, 10.1016/j.neubiorev.2013.05.006

Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041

Beydoun, 2012, Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline, Neurobiol. Aging, 33, 720, 10.1016/j.neurobiolaging.2010.05.017

Janicki, 2014, Estrogen receptor alpha variants affect age at onset of Alzheimer’s disease in a multiethnic female cohort, Dement. Geriatr. Cogn. Disord., 38, 200, 10.1159/000355559

Tisato, V., Zuliani, G., Vigliano, M., Longo, G., Franchini, E., Secchiero, P., Zauli, G., Paraboschi, E.M., Vikram Singh, A., and Serino, M.L. (2018). Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases. PLoS ONE, 13.

Peters, 2015, The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer’s disease: Two sides of the same coin, Neurobiol. Dis., 81, 49, 10.1016/j.nbd.2015.08.007

Hardy, 1992, Alzheimer’s disease: The amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067

Tanzi, 2005, Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008

Bush, 2008, Therapeutics for Alzheimer’s disease based on the metal hypothesis, Neurotherapeutics, 5, 421, 10.1016/j.nurt.2008.05.001

Schengrund, 2014, HFE gene variants, iron, and lipids: A novel connection in Alzheimer’s disease, Front. Pharmacol., 5, 165

Riedel, 2016, Age, APOE and sex: Triad of risk of Alzheimer’s disease, J. Steroid Biochem. Mol. Biol., 160, 134, 10.1016/j.jsbmb.2016.03.012

Burger, 2002, Hormonal changes in the menopause transition, Recent Prog. Horm. Res., 57, 257, 10.1210/rp.57.1.257

Li, 2014, Brain sex matters: Estrogen in cognition and Alzheimer’s disease, Mol. Cell. Endocrinol., 389, 13, 10.1016/j.mce.2013.12.018

Toro, 2019, Sex differences in Alzheimer’s disease: Understanding the molecular impact, Brain Res., 1719, 194, 10.1016/j.brainres.2019.05.031

Webers, A., Heneka, M.T., and Gleeson, P.A. (2019). The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer’s disease. Immunol. Cell Biol.

Cervellati, 2016, Oxidative challenge in Alzheimer’s disease: State of knowledge and future needs, J. Investig. Med., 64, 21, 10.1136/jim-2015-000017

Cervellati, 2019, Evaluating the link between Paraoxonase-1 levels and Alzheimer’s disease development, Minerva Med., 110, 238, 10.23736/S0026-4806.18.05875-5

Brombo, 2018, Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease, Gerontology, 64, 414, 10.1159/000488318

Tisato, 2016, Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment, Dement. Geriatr. Cogn. Disord., 41, 273, 10.1159/000446275

Bundy, 2019, Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer’s disease: A multi-omic analysis, J. Comp. Neurol., 527, 462, 10.1002/cne.24551

Strafella, 2018, Application of Precision Medicine in Neurodegenerative Diseases, Front. Neurol., 9, 701, 10.3389/fneur.2018.00701

Hosp, 2017, A Primer on Concepts and Applications of Proteomics in Neuroscience, Neuron, 96, 558, 10.1016/j.neuron.2017.09.025

Avramouli, 2017, Integrating Omic Technologies in Alzheimer’s Disease, Adv. Exp. Med. Biol., 987, 177, 10.1007/978-3-319-57379-3_16

Bundy, J.L., Vied, C., and Nowakowski, R.S. (2017). Sex differences in the molecular signature of the developing mouse hippocampus. BMC Genom., 18.

Zaidi, 2018, Regulation of Skeletal Homeostasis, Endocr. Rev., 39, 701, 10.1210/er.2018-00050

Siddiqui, 2016, Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement, Physiology, 31, 233, 10.1152/physiol.00061.2014

Kenkre, 2018, The bone remodelling cycle, Ann. Clin. Biochem., 55, 308, 10.1177/0004563218759371

Feng, 2011, Disorders of bone remodeling, Annu. Rev. Pathol., 6, 121, 10.1146/annurev-pathol-011110-130203

Stapleton, M., Sawamoto, K., Almeciga-Diaz, C.J., Mackenzie, W.G., Mason, R.W., Orii, T., and Tomatsu, S. (2017). Development of Bone Targeting Drugs. Int. J. Mol. Sci., 18.

Loeffler, 2018, The Metabolic Microenvironment Steers Bone Tissue Regeneration, Trends Endocrinol. Metab., 29, 99, 10.1016/j.tem.2017.11.008

Kassem, 2015, Skeletal stem cells in space and time, Cell, 160, 17, 10.1016/j.cell.2014.12.034

Tsai, 2017, Identification of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration, Stem Cell Rep., 8, 387, 10.1016/j.stemcr.2017.01.004

Han, 2018, Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts, Bone Res., 6, 16, 10.1038/s41413-018-0019-6

Szulc, 2018, Bone turnover: Biology and assessment tools, Best Pract. Res. Clin. Endocrinol. Metab., 32, 725, 10.1016/j.beem.2018.05.003

Lopes, 2018, Bone physiology as inspiration for tissue regenerative therapies, Biomaterials, 185, 240, 10.1016/j.biomaterials.2018.09.028

Yellowley, 2019, Hypoxia Signalling in the Skeleton: Implications for Bone Health, Curr. Osteoporos. Rep., 17, 26, 10.1007/s11914-019-00500-6

Spyropoulou, 2015, Mechanotransduction pathways in bone pathobiology, Biochim. Biophys. Acta, 1852, 1700, 10.1016/j.bbadis.2015.05.010

Compston, 2019, Osteoporosis, Lancet, 393, 364, 10.1016/S0140-6736(18)32112-3

Fuggle, 2019, Fracture prediction, imaging and screening in osteoporosis, Nat. Rev. Endocrinol., 15, 535, 10.1038/s41574-019-0220-8

Richards, 2012, Genetics of osteoporosis from genome-wide association studies: Advances and challenges, Nat. Rev. Genet., 13, 576, 10.1038/nrg3228

Sobacchi, 2013, Osteopetrosis: Genetics, treatment and new insights into osteoclast function, Nat. Rev. Endocrinol., 9, 522, 10.1038/nrendo.2013.137

Alonso, 2017, Clinical and Genetic Advances in Paget’s Disease of Bone: A Review, Clin. Rev. Bone Miner. Metab., 15, 37, 10.1007/s12018-016-9226-0

Lee, 2017, Energy Metabolism of the Osteoblast: Implications for Osteoporosis, Endocr. Rev., 38, 255, 10.1210/er.2017-00064

Raterman, 2019, Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis, Drugs, 79, 1065, 10.1007/s40265-019-01145-6

Adler, 2018, Update on osteoporosis in men, Best Pract. Res. Clin. Endocrinol. Metab., 32, 759, 10.1016/j.beem.2018.05.007

Zuo, 2017, Nuclear Receptors in Skeletal Homeostasis, Curr. Top. Dev. Biol., 125, 71, 10.1016/bs.ctdb.2017.01.002

Khosla, S., and Monroe, D.G. (2018). Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb. Perspect. Med., 8.

Yakar, 2018, Insulin-like growth factors: Actions on the skeleton, J. Mol. Endocrinol., 61, T115, 10.1530/JME-17-0298

Locatelli, 2014, Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis, Int. J. Endocrinol., 2014, 235060, 10.1155/2014/235060

Ukon, Y., Makino, T., Kodama, J., Tsukazaki, H., Tateiwa, D., Yoshikawa, H., and Kaito, T. (2019). Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review. Int. J. Mol. Sci., 20.

Taes, 2013, Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy, Bone, 54, 92, 10.1016/j.bone.2013.01.039

Wierckx, 2012, Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy, J. Clin. Endocrinol. Metab., 97, 2503, 10.1210/jc.2012-1187

Reppe, 2017, Omics analysis of human bone to identify genes and molecular networks regulating skeletal remodeling in health and disease, Bone, 101, 88, 10.1016/j.bone.2017.04.012

Lv, H., Jiang, F., Guan, D., Lu, C., Guo, B., Chan, C., Peng, S., Liu, B., Guo, W., and Zhu, H. (2016). Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research. Int. J. Mol. Sci., 17.

Bjornerem, 2018, Menopause-Related Appendicular Bone Loss is Mainly Cortical and Results in Increased Cortical Porosity, J. Bone Miner. Res., 33, 598, 10.1002/jbmr.3333

Almeida, 2017, Estrogens and Androgens in Skeletal Physiology and Pathophysiology, Physiol. Rev., 97, 135, 10.1152/physrev.00033.2015

Manolagas, 2013, The role of estrogen and androgen receptors in bone health and disease, Nat. Rev. Endocrinol., 9, 699, 10.1038/nrendo.2013.179

Vignozzi, 2019, Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO, J. Endocrinol. Invest., 42, 609, 10.1007/s40618-018-0978-x

Vanderschueren, 2014, Sex steroid actions in male bone, Endocr. Rev., 35, 906, 10.1210/er.2014-1024

Levin, 2018, Estrogen therapy for osteoporosis in the modern era, Osteoporos. Int., 29, 1049, 10.1007/s00198-018-4414-z

Jin, 2017, Hormone Therapy for Primary Prevention of Chronic Conditions in Postmenopausal Women, JAMA, 318, 2265, 10.1001/jama.2017.18440

Ramchand, 2018, Advances and Unmet Needs in the Therapeutics of Bone Fragility, Front. Endocrinol., 9, 505, 10.3389/fendo.2018.00505

Gurney, 2014, The Women’s Health Initiative trial and related studies: 10 years later: A clinician’s view, J. Steroid Biochem. Mol. Biol., 142, 4, 10.1016/j.jsbmb.2013.10.009

Mikkola, 2015, Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality, Menopause, 22, 976, 10.1097/GME.0000000000000450

2007, Hormones and heart disease in women: The timing hypothesis, Am. J. Epidemiol., 166, 506, 10.1093/aje/kwm214

Gambacciani, 2019, Hormone replacement therapy and prevention of chronic conditions, Climacteric, 22, 303, 10.1080/13697137.2018.1551347

Davis, 2019, Global Consensus Position Statement on the Use of Testosterone Therapy for Women, J. Clin. Endocrinol. Metab., 104, 4660, 10.1210/jc.2019-01603

Collaborative Group on Hormonal Factors in Breast Cancer (2019). Type and timing of menopausal hormone therapy and breast cancer risk: Individual participant meta-analysis of the worldwide epidemiological evidence. Lancet, 394, 1159–1168.

Baber, 2016, 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy, Climacteric, 19, 109, 10.3109/13697137.2015.1129166

Jared, D. (1997). Guns, Germs, and Steel: The Fates of Human Societies, W. W. Norton & Company.

Kay, 2014, Recovery of a medieval Brucella melitensis genome using shotgun metagenomics, MBio, 5, e01337-14, 10.1128/mBio.01337-14

Guellil, 2018, Genomic blueprint of a relapsing fever pathogen in 15th century Scandinavia, Proc. Natl. Acad. Sci. USA, 115, 10422, 10.1073/pnas.1807266115

Rascovan, 2019, Emergence and spread of basal lineages of Yersinia pestis during the Neolithic decline, Cell, 176, 295, 10.1016/j.cell.2018.11.005

Hall, 2018, Linking sex differences to the evolution of infectious disease life-histories, Philos. Trans. R. Soc. B Biol. Sci., 373, 20170431, 10.1098/rstb.2017.0431

Bramanti, 2003, Ancient DNA analysis of the delta F508 mutation, Hum. Biol., 75, 105, 10.1353/hub.2003.0017

Hughes, 2015, The biology and evolution of mammalian Y chromosomes, Annu. Rev. Genet., 49, 507, 10.1146/annurev-genet-112414-055311

Washburn, 1965, Sex differences in susceptibility to infections, Pediatrics, 35, 57, 10.1542/peds.35.1.57

World Health Organization (2007). Addressing Sex and Gender in Epidemic-Prone Infectious Diseases, World Health Organization.

Bramanti, 2019, The Third Plague Pandemic in Europe, Proc. R. Soc. B, 286, 20182429, 10.1098/rspb.2018.2429

Pandey, 2002, Gender differences in healthcare-seeking during common illnesses in a rural community of West Bengal, India, J. Health Popul. Nutr., 20, 306

Mitra, 2000, Risk factors and gender differentials for death among children hospitalized with diarrhoea in Bangladesh, J. Health Popul. Nutr., 18, 151

Markle, 2014, SeXX matters in immunity, Trends Immunol., 35, 97, 10.1016/j.it.2013.10.006

Reardon, 2016, Infections reveal inequality between the sexes, Nat. News, 534, 447, 10.1038/534447a

Fish, 2008, The X-files in immunity: Sex-based differences predispose immune responses, Nat. Rev. Immunol., 8, 737, 10.1038/nri2394

Vom Steeg, L.G., and Klein, S.L. (2016). SeXX matters in infectious disease pathogenesis. PLoS Pathog., 12.

Klein, 2012, Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases, Bioessays, 34, 1050, 10.1002/bies.201200099

Jansen, 2016, The evolution of sex-specific virulence in infectious diseases, Nat. Commun., 7, 13849, 10.1038/ncomms13849

Klein, 2015, Sex-based differences in immune function and responses to vaccination, Trans. R. Soc. Trop. Med. Hyg., 109, 9, 10.1093/trstmh/tru167

Marriott, 2006, Sexual dimorphism in innate immune responses to infectious organisms, Immunol. Res., 34, 177, 10.1385/IR:34:3:177

Schurz, 2019, The X chromosome and sex-specific effects in infectious disease susceptibility, Hum. Genom., 13, 2, 10.1186/s40246-018-0185-z

Jaillon, 2019, Sexual Dimorphism in Innate Immunity, Clin. Rev. Allergy Immunol., 56, 308, 10.1007/s12016-017-8648-x

Guerra-Silveira, F., and Abad-Franch, F. (2013). Sex bias in infectious disease epidemiology: Patterns and processes. PLoS ONE, 8.

Klein, 2004, Hormonal and immunological mechanisms mediating sex differences in parasite infection, Parasite Immunol., 26, 247, 10.1111/j.0141-9838.2004.00710.x

Roberts, 2001, Sex-associated hormones and immunity to protozoan parasites, Clin. Microbiol. Rev., 14, 476, 10.1128/CMR.14.3.476-488.2001

Borgdorff, 1998, Mortality among tuberculosis patients in The Netherlands in the period 1993–1995, Eur. Respir. J., 11, 816, 10.1183/09031936.98.11040816

DeRiemer, 2006, Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area, Thorax, 61, 348, 10.1136/thx.2005.049452

Zumla, 2015, The WHO 2014 global tuberculosis report—Further to go, Lancet Glob. Health, 3, e10, 10.1016/S2214-109X(14)70361-4

Bellamy, 2000, Genetic susceptibility to tuberculosis in Africans: A genome-wide scan, Proc. Natl. Acad. Sci. USA, 97, 8005, 10.1073/pnas.140201897

Bernin, 2014, Sex bias in the outcome of human tropical infectious diseases: Influence of steroid hormones, J. Infect. Dis., 209, S107, 10.1093/infdis/jit610

Pathak, S., Rege, M., Gogtay, N.J., Aigal, U., Sharma, S.K., Valecha, N., Bhanot, G., Kshirsagar, N.A., and Sharma, S. (2012). Age-dependent sex bias in clinical malarial disease in hypoendemic regions. PLoS ONE, 7.

Karami, 2013, Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran, J. Vector Borne Dis., 50, 30, 10.4103/0972-9062.112532

Marlow, M.A., da Silva Mattos, M., Makowiecky, M.E., Eger, I., Rossetto, A.L., Grisard, E.C., and Steindel, M. (2013). Divergent profile of emerging cutaneous leishmaniasis in subtropical Brazil: New endemic areas in the southern frontier. PLoS ONE, 8.

Murback, 2011, American cutaneous leishmaniasis: Clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil, An. Bras. Dermatol., 86, 55, 10.1590/S0365-05962011000100007

Sarkari, 2012, Epidemiological features of visceral leishmaniasis in Fars province, southern Iran, Iran. J. Public Health, 41, 94

McClelland, E.E., Hobbs, L.M., Rivera, J., Casadevall, A., Potts, W.K., Smith, J.M., and Ory, J.J. (2013). The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS ONE, 8.

Aaby, 1995, Non-specific beneficial effect of measles immunisation: Analysis of mortality studies from developing countries, BMJ, 311, 481, 10.1136/bmj.311.7003.481

Ingersoll, M.A. (2017). Sex differences shape the response to infectious diseases. PLoS Pathog., 13.

Harper, 2007, 3. Management of urinary tract infections in men, Trends Urol. Gynaecol. Sex. Health, 12, 30, 10.1002/tre.8

Furman, 2014, Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination, Proc. Natl. Acad. Sci. USA, 111, 869, 10.1073/pnas.1321060111

Dance, 2019, Why the sexes don’t feel pain the same way, Nature, 567, 448, 10.1038/d41586-019-00895-3

Fillingim, 2009, Sex, gender, and pain: A review of recent clinical and experimental findings, J. Pain, 10, 447, 10.1016/j.jpain.2008.12.001

Bartley, 2013, Sex differences in pain: A brief review of clinical and experimental findings, Br. J. Anaesth., 111, 52, 10.1093/bja/aet127

Darnall, 2012, Medical and psychological risks and consequences of long-term opioid therapy in women, Pain Med., 13, 1181, 10.1111/j.1526-4637.2012.01467.x

Simpson, 2014, Empathy: Gender effects in brain and behavior, Neurosci. Biobehav. Rev., 46, 604, 10.1016/j.neubiorev.2014.09.001

Albert, 2015, Why is depression more prevalent in women?, J. Psychiatry Neurosci., 40, 219, 10.1503/jpn.150205

Packiasabapathy, 2018, Gender, genetics, and analgesia: Understanding the differences in response to pain relief, J. Pain Res., 11, 2729, 10.2147/JPR.S94650

Ray, 2016, Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury, Neural Regen. Res., 11, 1418, 10.4103/1673-5374.191212

Bi, 2003, Effects of estrogen, age, and calpain on MAP kinase and NMDA receptors in female rat brain, Neurobiol. Aging, 24, 977, 10.1016/S0197-4580(03)00012-5

Tang, 2008, Estrogen alters spinal NMDA receptor activity via a PKA signalling pathway in a visceral pain model in the rat, Pain, 137, 540, 10.1016/j.pain.2007.10.017

Deng, 2017, Estrogen affects neuropathic pain through upregulating N-methyl-D-aspartate acid receptor 1 expression in the dorsal root ganglion of rats, Neural Regen. Res., 12, 464, 10.4103/1673-5374.202925

Islas, 2018, TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain, Proc. Natl. Acad. Sci. USA, 115, E1657

Clark, 2016, Preclinical Pain Research: Can We Do Better?, Anesthesiology, 125, 846, 10.1097/ALN.0000000000001340

Travers, 2009, Gender and pain is it an issue?, SAJAA, 15, 7

Mazure, 2016, Our evolving science: Studying the influence of sex in preclinical research, Biol. Sex Differ., 7, 15, 10.1186/s13293-016-0068-8

Mazure, C.M., and Jones, D.P. (2015). Twenty years and still counting: Including women as participants and studying sex and gender in biomedical research. BMC Womens Health, 15.

Sorge, 2011, Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice, J. Neurosci., 31, 15450, 10.1523/JNEUROSCI.3859-11.2011

Sorge, 2015, Different immune cells mediate mechanical pain hypersensitivity in male and female mice, Nat. Neurosci., 18, 1081, 10.1038/nn.4053

Yamamotova, 2017, Do multiple body modifications alter pain threshold?, Physiol. Res., 66, S493, 10.33549/physiolres.933804

Belfer, 2017, Pain in women, Agri, 29, 51

Aloisi, 2007, Cross-sex hormone administration changes pain in transsexual women and men, Pain, 132, S60, 10.1016/j.pain.2007.02.006

Fisher, 2010, Sex, gender, and pharmaceutical politics: From drug development to marketing, Gend. Med., 7, 357, 10.1016/j.genm.2010.08.003

Doyle, 2017, Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine, J. Neurosci., 37, 3202, 10.1523/JNEUROSCI.2906-16.2017

Averitt, 2019, Neuronal and glial factors contributing to sex differences in opioid modulation of pain, Neuropsychopharmacology, 44, 155, 10.1038/s41386-018-0127-4

Aubrun, 2005, Sex- and age-related differences in morphine requirements for postoperative pain relief, Anesthesiology, 103, 156, 10.1097/00000542-200507000-00023

Els, 2017, Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: An overview of Cochrane Reviews, Cochrane Database Syst. Rev., 10, CD012509

Legato, M., and Glezerman, M. (2017). The International Society for Gender Medicine, Academic Press. [1st ed.].

Gianazza, 2018, Gender proteomics I. Which proteins in non-sexual organs, J. Proteom., 178, 7, 10.1016/j.jprot.2017.10.002

Gianazza, 2018, Gender proteomics II. Which proteins in sexual organs, J. Proteom., 178, 18, 10.1016/j.jprot.2017.10.001

Arnold, 2012, Understanding the sexome: Measuring and reporting sex differences in gene systems, Endocrinology, 153, 2551, 10.1210/en.2011-2134

Arnold, 2010, Promoting the understanding of sex differences to enhance equity and excellence in biomedical science, Biol. Sex Differ., 1, 1, 10.1186/2042-6410-1-1

Arnold, 2004, Sex chromosomes and brain gender, Nat. Rev. Neurosci., 5, 701, 10.1038/nrn1494

Harvey, 2015, Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease, Womens Health, 11, 239

Dorak, 2012, Gender differences in cancer susceptibility: An inadequately addressed issue, Front. Genet., 3, 268, 10.3389/fgene.2012.00268

(2019, December 13). Available online: http://ec.europa.eu/research/health/pdf/2013-10_personalised_medicine_en.pdf.

Johnson, P.A., Fitzgerald, T., Glynn, A., Salganicoff, A., Wood, S.F., and Goldstein, J.M. (2016, December 13). Precision Medicine: How Sex and Gender Drive Innovation. Available online: http://www.tbf.org/~/media/TBFOrg/Files/Reports/ConnorsCenterBrochure-2016.pdf2016.

Panagiotou, 2009, Nutritional systems biology: Definitions and approaches, Annu. Rev. Nutr., 29, 329, 10.1146/annurev-nutr-080508-141138

Hamishehkar, 2016, Vitamins, Are They Safe?, Adv. Pharm. Bull., 6, 467, 10.15171/apb.2016.061

Biesalski, 2017, Multivitamin/mineral supplements: Rationale and safety—A systematic review, Nutrition, 33, 76, 10.1016/j.nut.2016.02.013

Tisato, V., Muggeo, P., Lupiano, T., Longo, G., Serino, M.L., Grassi, M., Arcamone, E., Secchiero, P., Zauli, G., and Santoro, N. (2019). Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS). Genes, 10.